patent

United States Patent 6,288,045
Kaufman September 11, 2001
Epithelial cell cancer drug


Abstract

A method of treating epithelial cell cancer comprising administering to a mammalian patient diagnosed as having an epithelial cell cancer a therapeutically effective amount of 4,5 di-cyclo, disilico, dimagnesium, dialumino, oxyo, trihydrate, or its acetate, sulfate, hydrochlorate, or brominate salts. The composition is synthesized from a naturally occurring non-toxic zeolites, and has a 100% kill rate within 72 hours against buccal mucosa and ling squamous epithelial cell cancers. It is not cytoxic to healthy human cells.
Inventors: Kaufman; Harvey (Hudson, OH)
Assignee: Lifelink Pharmaceuticals, Inc. (Stow, OH)
Appl. No.: 591701
Filed: June 9, 2000